What is the latest technology for Rigicon penile implants?

Rigicon has established itself as an innovative manufacturer in the field of penile prosthetics, offering two distinct implant types designed to address erectile dysfunction when other treatments have failed. Their product line includes the Infla10^® inflatable penile prosthesis (IPP) and the Rigi10^TM malleable penile prosthesis (MPP), both featuring advanced design elements that address key clinical needs³. The Rigi10^TM malleable penile prosthesis represents a significant advancement in semi-rigid implant technology. Unlike competitors that offer only three cylinder widths, the Rigi10^TM is available in six different widths (9, 10, 11, 12, 13, and 14 mm), allowing surgeons to achieve more precise anatomical customization⁴. This expanded size range has proven clinically valuable, with the 12 mm cylinder (unavailable from competitors) being the second most frequently used size in global studies. The device features highly flexible stainless-steel wires covered with Teflon and silicone, improving concealability while maintaining necessary rigidity5. A comprehensive multicenter study across 15 countries with 605 patients demonstrated exceptional safety outcomes, with a three-year implant survival rate of 99.2% and less than 1% of patients requiring reoperation for any reason6. The study reported extremely low rates of infection (0.33%) and erosion (0.16%), with patient dissatisfaction at just 0.50%⁷. The Infla10^® inflatable penile prosthesis represents Rigicon’s premium solution for patients seeking the most natural erection experience. This three-piece system includes cylinders, a scrotal pump, and a fluid reservoir. A large multicenter study of 535 patients across 15 countries showed impressive safety outcomes, with freedom from revision surgery rates of 96.4% at one year, 95.0% at two years, and 94.0% at three years⁸. The study reported a mechanical failure rate of only 2.24%, an infection rate of just 0.19%, and a patient dissatisfaction rate of merely 0.56%⁹. The Infla10^® is available in three different cylinder types: Infla10^® X (girth expansion), Infla10^® AX (length and girth expansion), and Infla10^® Narrow Body¹⁰. Patient satisfaction with Rigicon devices has been documented in multiple clinical studies. A satisfaction study for the Infla10^® inflatable prosthesis found that 91.4% of patients were satisfied at 6 months postoperatively and would recommend the procedure¹¹. The most common reasons for diminished satisfaction were perceived penile shortening (5.1%) and difficulty learning pump cycling (3.4%)¹². The Rigi10^TM malleable prosthesis demonstrated a remarkably low patient dissatisfaction rate of just 0.49% in worldwide implantations¹³. These high satisfaction rates reflect Rigicon’s commitment to designing prostheses that balance rigidity, comfort, and discretion. Both Rigicon prostheses incorporate advanced infection-prevention technology. The devices feature hydrophilic coatings designed to reduce infection risk, a critical advancement since infection remains one of the most serious complications of penile implant surgery¹⁴. This focus on infection prevention has yielded impressive results, with infection rates of 0.33% for the Rigi10^TM and 0.19% for the Infla10^®, significantly lower than historical rates reported for penile prostheses¹⁵. Rigicon offers specialized surgical tools like the HL Dilator^TM that complement their implants and may help reduce surgical complications^16. The company’s products are used in advanced surgical techniques for complex cases, including Peyronie’s disease and transgender phalloplasty¹⁷ Rigicon has 30 years of experience in urology and focuses exclusively on innovative prosthetic urology solutions¹⁸